Annals of Neurology, ISSN 0364-5134, 08/2019, Volume 86, Issue 2, pp. 326 - 327
Journal Article
Annals of Neurology, ISSN 0364-5134, 08/2019, Volume 86, Issue 2, pp. 326 - 327
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2014, Volume 111, Issue 43, pp. 15550 - 15555
Autism spectrum disorder (ASD), characterized by both impaired communication and social interaction, and by Stereotypie behavior, affects about 1 in 68,...
Acute stress disorders | Oxidative stress | Broccoli | Autistic disorder | Atrial heart septal defects | Sprouts | Social interaction | Pervasive child development disorders | Placebos | Fever | ACTIVATION | CLINICAL-TRIAL | BROCCOLI | ENZYMES | CHINA | MULTIDISCIPLINARY SCIENCES | CHEMOPREVENTION | STRESS | CANCER | CHILDREN | Young Adult | Isothiocyanates - therapeutic use | Social Behavior | Humans | Adolescent | Adult | Male | Treatment Outcome | Child Development Disorders, Pervasive - drug therapy | Isothiocyanates - adverse effects | Care and treatment | Usage | Phytochemicals | Pervasive developmental disorders | Dosage and administration | Health aspects | Organosulfur compounds | Biological Sciences
Acute stress disorders | Oxidative stress | Broccoli | Autistic disorder | Atrial heart septal defects | Sprouts | Social interaction | Pervasive child development disorders | Placebos | Fever | ACTIVATION | CLINICAL-TRIAL | BROCCOLI | ENZYMES | CHINA | MULTIDISCIPLINARY SCIENCES | CHEMOPREVENTION | STRESS | CANCER | CHILDREN | Young Adult | Isothiocyanates - therapeutic use | Social Behavior | Humans | Adolescent | Adult | Male | Treatment Outcome | Child Development Disorders, Pervasive - drug therapy | Isothiocyanates - adverse effects | Care and treatment | Usage | Phytochemicals | Pervasive developmental disorders | Dosage and administration | Health aspects | Organosulfur compounds | Biological Sciences
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 5, pp. 435 - 442
Summary Background Mutations in SOD1 cause 13% of familial amyotrophic lateral sclerosis. In the SOD1 Gly93Ala rat model of amyotrophic lateral sclerosis, the...
Neurology | WILD-TYPE | THERAPIES | SUPEROXIDE-DISMUTASE | CLINICAL NEUROLOGY | DISEASE | Injections, Spinal | Superoxide Dismutase - genetics | Double-Blind Method | Oligodeoxyribonucleotides, Antisense - administration & dosage | Amyotrophic Lateral Sclerosis - genetics | Humans | Middle Aged | Oligodeoxyribonucleotides, Antisense - therapeutic use | Male | Treatment Outcome | Amyotrophic Lateral Sclerosis - drug therapy | Adult | Female | Superoxide Dismutase-1 | Amyotrophic lateral sclerosis | Genetic aspects | RNA | Analysis | Index Medicus
Neurology | WILD-TYPE | THERAPIES | SUPEROXIDE-DISMUTASE | CLINICAL NEUROLOGY | DISEASE | Injections, Spinal | Superoxide Dismutase - genetics | Double-Blind Method | Oligodeoxyribonucleotides, Antisense - administration & dosage | Amyotrophic Lateral Sclerosis - genetics | Humans | Middle Aged | Oligodeoxyribonucleotides, Antisense - therapeutic use | Male | Treatment Outcome | Amyotrophic Lateral Sclerosis - drug therapy | Adult | Female | Superoxide Dismutase-1 | Amyotrophic lateral sclerosis | Genetic aspects | RNA | Analysis | Index Medicus
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 2013, Volume 70, Issue 5, pp. 481 - 489
Importance: More effective treatments are needed for negative symptoms of schizophrenia, which are typically chronic, disabling, and costly. Negative symptoms...
METHYLENETETRAHYDROFOLATE REDUCTASE | FOLIC-ACID FORTIFICATION | HOMOCYSTEINE LEVELS | CONTROLLED-TRIAL | CATECHOL-O-METHYLTRANSFERASE | RISK-FACTOR | MYOCARDIAL-INFARCTION | NEGATIVE SYMPTOMS | PSYCHIATRY | PLASMA HOMOCYSTEINE | VASCULAR-DISEASE
METHYLENETETRAHYDROFOLATE REDUCTASE | FOLIC-ACID FORTIFICATION | HOMOCYSTEINE LEVELS | CONTROLLED-TRIAL | CATECHOL-O-METHYLTRANSFERASE | RISK-FACTOR | MYOCARDIAL-INFARCTION | NEGATIVE SYMPTOMS | PSYCHIATRY | PLASMA HOMOCYSTEINE | VASCULAR-DISEASE
Journal Article
General Hospital Psychiatry, ISSN 0163-8343, 12/2019
Journal Article
ANNALS OF NEUROLOGY, ISSN 0364-5134, 08/2019, Volume 86, Issue 2, pp. 326 - 327
Journal Article
Neurology, ISSN 0028-3878, 08/2016, Volume 87, Issue 8, pp. 806 - 814
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9934, pp. 2065 - 2072
Summary Background Amyotrophic lateral sclerosis is a fatal neurodegenerative disease with few therapeutic options. Mild obesity is associated with greater...
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | BENEFIT | ENERGY-EXPENDITURE | MANAGEMENT | PREDICTOR | NEUROLOGY | BODY-MASS INDEX | DEATH | ALS PATIENTS | DYSLIPIDEMIA | Enteral Nutrition - methods | Double-Blind Method | Amyotrophic Lateral Sclerosis - therapy | Cholesterol - blood | Humans | Middle Aged | Kaplan-Meier Estimate | Diet, High-Fat - adverse effects | Male | Amyotrophic Lateral Sclerosis - blood | Energy Intake | Enteral Nutrition - adverse effects | Pilot Projects | Adult | Female | Aged | Diet, High-Fat - methods | Amyotrophic lateral sclerosis | Diet therapy | Research | Health aspects | Tube feeding | Enteral feeding | Clinical trials | Care and treatment | Analysis | Nutrition research | Carbohydrates | Diet | Mortality | Metabolism
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | BENEFIT | ENERGY-EXPENDITURE | MANAGEMENT | PREDICTOR | NEUROLOGY | BODY-MASS INDEX | DEATH | ALS PATIENTS | DYSLIPIDEMIA | Enteral Nutrition - methods | Double-Blind Method | Amyotrophic Lateral Sclerosis - therapy | Cholesterol - blood | Humans | Middle Aged | Kaplan-Meier Estimate | Diet, High-Fat - adverse effects | Male | Amyotrophic Lateral Sclerosis - blood | Energy Intake | Enteral Nutrition - adverse effects | Pilot Projects | Adult | Female | Aged | Diet, High-Fat - methods | Amyotrophic lateral sclerosis | Diet therapy | Research | Health aspects | Tube feeding | Enteral feeding | Clinical trials | Care and treatment | Analysis | Nutrition research | Carbohydrates | Diet | Mortality | Metabolism
Journal Article
Blood, ISSN 0006-4971, 07/2004, Volume 104, Issue 1, pp. 34 - 39
Treatment of patients with beta-thalassemia major has improved dramatically during the past 40 years; however, the current clinical status of these patients...
SURVIVAL | CLEARANCE | VIRUS | DEFEROXAMINE | MANAGEMENT | DISEASE | DISORDERS | HEPATITIS-C VIREMIA | COOLEYS-ANEMIA | HEMATOLOGY | IRON-CHELATING THERAPY | Liver - pathology | beta-Thalassemia - epidemiology | Age Factors | Humans | Middle Aged | Child, Preschool | Endocrine System Diseases - etiology | Infant | beta-Thalassemia - complications | Deferoxamine - adverse effects | Liver Cirrhosis - epidemiology | Ferritins - blood | Heart Diseases - epidemiology | Adult | Retrospective Studies | Child | beta-Thalassemia - blood | Liver Cirrhosis - etiology | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Cross-Sectional Studies | Genotype | Iron - metabolism | Liver - chemistry | Endocrine System Diseases - epidemiology | Iron Chelating Agents - adverse effects | Transfusion Reaction | Heart Diseases - etiology | Iron Overload - epidemiology | Adolescent
SURVIVAL | CLEARANCE | VIRUS | DEFEROXAMINE | MANAGEMENT | DISEASE | DISORDERS | HEPATITIS-C VIREMIA | COOLEYS-ANEMIA | HEMATOLOGY | IRON-CHELATING THERAPY | Liver - pathology | beta-Thalassemia - epidemiology | Age Factors | Humans | Middle Aged | Child, Preschool | Endocrine System Diseases - etiology | Infant | beta-Thalassemia - complications | Deferoxamine - adverse effects | Liver Cirrhosis - epidemiology | Ferritins - blood | Heart Diseases - epidemiology | Adult | Retrospective Studies | Child | beta-Thalassemia - blood | Liver Cirrhosis - etiology | Iron Chelating Agents - therapeutic use | beta-Thalassemia - therapy | Cross-Sectional Studies | Genotype | Iron - metabolism | Liver - chemistry | Endocrine System Diseases - epidemiology | Iron Chelating Agents - adverse effects | Transfusion Reaction | Heart Diseases - etiology | Iron Overload - epidemiology | Adolescent
Journal Article
Annals of Neurology, ISSN 0364-5134, 04/2019, Volume 85, Issue 4, pp. 593 - 599
Objective LRRK2 mutations, the most common genetic cause of Parkinson disease (PD), display incomplete penetrance, indicating the importance of other genetic...
PENETRANCE | G2019S | RISK | SEX-DIFFERENCES | NEUROSCIENCES | CLINICAL NEUROLOGY | Parkinson's disease | Neurodegenerative diseases | Pathogenesis | Parkinsons disease | Sex | Regression analysis | Uric acid | Risk analysis | Risk factors | Carriers | Consortia | Antioxidants | Men | Biomarkers | Sampling methods | Hormone replacement therapy | Mutation | LRRK2 protein | Movement disorders
PENETRANCE | G2019S | RISK | SEX-DIFFERENCES | NEUROSCIENCES | CLINICAL NEUROLOGY | Parkinson's disease | Neurodegenerative diseases | Pathogenesis | Parkinsons disease | Sex | Regression analysis | Uric acid | Risk analysis | Risk factors | Carriers | Consortia | Antioxidants | Men | Biomarkers | Sampling methods | Hormone replacement therapy | Mutation | LRRK2 protein | Movement disorders
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2019, Volume 145, Issue 3, pp. 561 - 569
Patients with NF2 who are deaf or have significant hearing loss face numerous and unique challenges which lead to poor quality of life, and thus may benefit...
Mind–body program | Neurology | Medicine & Public Health | Neurofibromatosis | Deaf | Videoconferencing | Oncology | Resiliency | Communication access real-time translation
Mind–body program | Neurology | Medicine & Public Health | Neurofibromatosis | Deaf | Videoconferencing | Oncology | Resiliency | Communication access real-time translation
Journal Article
Autism: The International Journal of Research and Practice, ISSN 1362-3613, 02/2019, Volume 23, Issue 2, p. 468
The newest edition of the "Diagnostic and Statistical Manual of Mental Disorders" (5th ed., DSM-5) introduced substantial changes to the diagnostic criteria...
Intelligence Quotient | Diagnostic Tests | Age Differences | Severity (of Disability) | Emotional Problems | Autism | Interpersonal Communication | Behavior Problems | Pervasive Developmental Disorders | Observation | Children | Adolescents | Clinical Diagnosis | Symptoms (Individual Disorders)
Intelligence Quotient | Diagnostic Tests | Age Differences | Severity (of Disability) | Emotional Problems | Autism | Interpersonal Communication | Behavior Problems | Pervasive Developmental Disorders | Observation | Children | Adolescents | Clinical Diagnosis | Symptoms (Individual Disorders)
Journal Article
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ISSN 2167-8421, 09/2019, pp. 1 - 5
Journal Article
Neurology, ISSN 0028-3878, 08/2016, Volume 87, Issue 8, pp. 806 - 814
OBJECTIVE:To test, within a single-blind randomized controlled trial, the feasibility, acceptability, efficacy, and durability of a mind–body program (the...
Single-Blind Method | Follow-Up Studies | Outcome Assessment (Health Care) | Psychotherapy, Group - methods | Humans | Middle Aged | Male | Neurofibromatoses - complications | Feasibility Studies | Depression - etiology | Anxiety - therapy | Mind-Body Therapies - methods | Patient Acceptance of Health Care | Telemedicine - methods | Quality of Life | Videoconferencing | Adult | Female | Depression - therapy | Anxiety - etiology | Neurofibromatoses - therapy
Single-Blind Method | Follow-Up Studies | Outcome Assessment (Health Care) | Psychotherapy, Group - methods | Humans | Middle Aged | Male | Neurofibromatoses - complications | Feasibility Studies | Depression - etiology | Anxiety - therapy | Mind-Body Therapies - methods | Patient Acceptance of Health Care | Telemedicine - methods | Quality of Life | Videoconferencing | Adult | Female | Depression - therapy | Anxiety - etiology | Neurofibromatoses - therapy
Journal Article
Autism, ISSN 1362-3613, 2/2019, Volume 23, Issue 2, pp. 468 - 476
The newest edition of the Diagnostic and Statistical Manual of Mental Disorders (5th ed., DSM-5) introduced substantial changes to the diagnostic criteria for...
diagnosis | DSM-5 | need for support | autism spectrum disorder | severity level | CRITERIA | PSYCHOLOGY, DEVELOPMENTAL | DIAGNOSTIC OBSERVATION SCHEDULE | Emotional-Behavioural problems | Intelligence | Mental disorders | Decision making | Severity | Diagnostic and Statistical Manual | Stereotypes | Autistic children | Autism | Intelligence tests | Repetitive behaviour | Cognitive functioning | Ratings & rankings | Behavior | Stereotyped behaviour | Behavioural problems
diagnosis | DSM-5 | need for support | autism spectrum disorder | severity level | CRITERIA | PSYCHOLOGY, DEVELOPMENTAL | DIAGNOSTIC OBSERVATION SCHEDULE | Emotional-Behavioural problems | Intelligence | Mental disorders | Decision making | Severity | Diagnostic and Statistical Manual | Stereotypes | Autistic children | Autism | Intelligence tests | Repetitive behaviour | Cognitive functioning | Ratings & rankings | Behavior | Stereotyped behaviour | Behavioural problems
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 4/2018, Volume 137, Issue 2, pp. 321 - 329
The neurofibromatoses (NF) are incurable genetic disorders that can cause nerve sheath tumors, chronic pain, and disfiguration. Patients with NF report lower...
Intervention | Neurology | Medicine & Public Health | Neurofibromatosis | Oncology | Resiliency | Coping | Mindfulness | SCHWANNOMATOSIS | RELAXATION RESPONSE | CLINICAL NEUROLOGY | PILOT | ONCOLOGY | PSYCHOLOGICAL RESILIENCE | SOCIAL SUPPORT | QUALITY-OF-LIFE | STRESS | COPING STRATEGIES | HEALTH OUTCOMES | Medical colleges | Mindfulness meditation | Chronic pain | Social interactions | Pain | Attention | Quality of life | Tumors | Social support
Intervention | Neurology | Medicine & Public Health | Neurofibromatosis | Oncology | Resiliency | Coping | Mindfulness | SCHWANNOMATOSIS | RELAXATION RESPONSE | CLINICAL NEUROLOGY | PILOT | ONCOLOGY | PSYCHOLOGICAL RESILIENCE | SOCIAL SUPPORT | QUALITY-OF-LIFE | STRESS | COPING STRATEGIES | HEALTH OUTCOMES | Medical colleges | Mindfulness meditation | Chronic pain | Social interactions | Pain | Attention | Quality of life | Tumors | Social support
Journal Article
Schizophrenia Research, ISSN 0920-9964, 11/2012, Volume 141, Issue 2-3, pp. 215 - 221
The duration of untreated psychosis is well recognised as an independent predictor of symptomatic and functional outcome in the short term and has facilitated...
First-episode | Follow-up
First-episode | Follow-up
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 8, pp. 758 - 758
In the URICO-ICTUS stroke study, Chamorro and colleagues presented a predefined subgroup analysis of urate effects that showed an increased likelihood of an...
Neurology | SERUM | URIC-ACID | CLINICAL NEUROLOGY | PARKINSON DISEASE | Female | Male | Antioxidants - therapeutic use | Stroke - drug therapy | Uric Acid - therapeutic use | Humans | Womens health | Parkinsons disease | Men
Neurology | SERUM | URIC-ACID | CLINICAL NEUROLOGY | PARKINSON DISEASE | Female | Male | Antioxidants - therapeutic use | Stroke - drug therapy | Uric Acid - therapeutic use | Humans | Womens health | Parkinsons disease | Men
Journal Article
Movement Disorders, ISSN 0885-3185, 03/2016, Volume 31, Issue 3, pp. 417 - 421
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.